A Phase I Study of TRN501 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Parkinson Disease
- Interventions
- Drug: TRN501 - Dose 6Drug: TRN501 - Dose 4Drug: TRN501 - Dose 5Drug: TRN501 - Dose 1Drug: TRN501 - Dose 2Drug: TRN501 - Dose 3Drug: TRN501 - Dose 7Drug: TRN501 - Dose 8
- First Posted Date
- 2024-06-11
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- SNLD, Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT06453551
- Locations
- 🇯🇵
Clinical Research Hospital Tokyo, Shinjuku-ku, Tokyo, Japan
Phase II Clinical Study of TR-012001 in Japanese Patients With Parkinson's Disease
- First Posted Date
- 2024-01-18
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- SNLD, Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06212089
- Locations
- 🇯🇵
Saiseikai Imabari Hospital, Imabari, Ehime Prefecture, Japan
© Copyright 2025. All Rights Reserved by MedPath